HRMY

HARMONY BIOSCIENCES HOLDINGS, INC.

HRMY · CIK 1802665 · Annual (10-K) · Last 6 years

Financial Trends

Revenue$868M
20202025
Net Income$159M
20202025
Operating CF$348M
20202025
Free Cash Flow$348M
20202025

Income Statement

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue$0.9B$0.7B$0.6B$0.4B$0.3B$0.2B
Cost of Revenue$0.2B$0.2B$0.1B$0.1B$0.1B$0.0B
Gross Profit$0.7B$0.6B$0.5B$0.4B$0.2B$0.1B
R&D Expense$0.2B$0.1B$0.1B$0.1B$0.0B$0.0B
SG&A Expense
Operating Income$0.2B$0.2B$0.2B$0.1B$0.1B$0.0B
Net Income$0.2B$0.1B$0.1B$0.2B$0.0B$-0.0B
EPS (Basic)$2.76$2.56$2.17$3.07$0.60$-2.48
EPS (Diluted)$2.71$2.51$2.13$2.97$0.58$-2.48

Balance Sheet

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Total Assets$1.3B$1.0B$0.8B$0.7B$0.4B$0.4B
Current Assets$0.9B$0.6B$0.5B$0.4B$0.3B$0.3B
Cash & Equivalents$0.8B$0.5B$0.3B$0.2B$0.2B$0.2B
Total Liabilities$0.4B$0.3B$0.3B$0.3B$0.2B$0.3B
Current Liabilities$0.3B$0.2B$0.2B$0.1B$0.1B$0.1B
Stockholders' Equity$0.9B$0.7B$0.5B$0.4B$0.2B$0.1B

Cash Flow Statement

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Operating Cash Flow$0.3B$0.2B$0.2B$0.1B$0.1B$-0.0B
Investing Cash Flow$-0.0B$-0.1B$-0.0B$-0.1B$-0.1B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$-0.0B$-0.0B$-0.1B$0.0B$0.0B$0.2B